WNYUZ
No Result
View All Result
  • Home
  • Politics
  • Opinion
  • Business
  • World
  • Health
  • Entertainment
  • Tech
  • Home
  • Politics
  • Opinion
  • Business
  • World
  • Health
  • Entertainment
  • Tech
No Result
View All Result
WNYUZ
No Result
View All Result
Home News

New annual shot could replace monthly flea, tick treatments, FDA says

July 11, 2025
in News
Yahoo news home
491
SHARES
1.4k
VIEWS
Share on FacebookShare on Twitter

Dogs across the U.S. could soon get longer-lasting protection against pesky parasites thanks to a new treatment approved by federal regulators Thursday.

The U.S. Food and Drug Administration has given the green light to Bravecto Quantum, the first-ever flea and tick preventative that can protect dogs for up to 12 months with a single injection. The treatment is approved for dogs and puppies 6 months and older.

The new shot is an alternative to treatments that usually need to be given every month or every few months.

“Fluralaner, the active ingredient in Bravecto Quantum, can be an important part of parasite control depending on where pet owners live in the country,” said Dr. Tina Wismer, senior director of toxicology at ASPCA Poison Control, in an email to ABC News. “A long-term flea and tick preventative can be a useful option for dog owners who live in areas where year-round protection is necessary, or for those who might not be able or remember to administer treatment on a monthly or quarterly basis.”

MORE: Male infertility: 5 lifestyle factors that could be hurting your fertility

The injectable treatment must be administered by a licensed veterinarian, who will determine whether an 8- or 12-month protection period is appropriate based on local tick species. Veterinarians will also monitor for potential side effects.

While the drug belongs to a commonly used and safe class of medications called isoxazolines, some dogs may experience neurologic side effects, including muscle tremors and seizures.

Julie Cappiello, with Voters For Animal Rights, an advocacy organization, said she welcomes the new treatment but emphasized caution.

“As someone who spends a great deal of time outdoors with my dog, I see the convenience of a long-lasting, 12-month flea and tick preventative like Bravecto Quantum,” she said in a statement. “However, it’s important to recognize that no single treatment is right for every dog, and all medications come with potential risks.”

The new treatment is manufactured by Intervet, Inc., based in Rahway, New Jersey.

Pet owners interested in the new treatment option should consult their veterinarians to determine if it’s appropriate for their dogs, particularly those with a history of neurological issues.

The post New annual shot could replace monthly flea, tick treatments, FDA says appeared first on ABC News.

Tags: ABC NewsBravecto Quantumdogs and puppiesfederal regulatorsflea and tickFood and Drug AdministrationGerman Shepherd dogveterinarianYahooYahoo News
Share196Tweet123Share
Dutch government took control of Nexperia over fears it was being gutted
News

Dutch government took control of Nexperia over fears it was being gutted

October 28, 2025

AMSTERDAM (Reuters) -The Netherlands' decision to take control of chipmaker Nexperia in September was due to fears the company's former ...

Read more
News

Saudi AI firm Humain eyes dual listing on Saudi, NASDAQ exchanges within four years

October 28, 2025
News

Amazon says it plans to cut about 14,000 corporate jobs

October 28, 2025
News

Foxconn to invest up to $1.37 billion in AI compute cluster, supercomputing centre

October 28, 2025
News

Exclusive-Amazon targets as many as 30,000 corporate job cuts, sources say

October 27, 2025
UK faces $26.8 billion public finances gap from productivity cut, FT reports

UK faces $26.8 billion public finances gap from productivity cut, FT reports

October 27, 2025
Carbon Measures global accounting group to form independent panel

Carbon Measures global accounting group to form independent panel

October 27, 2025
Novo-backed MapLight valued at $787 million after shares jump in Nasdaq debut

Novo-backed MapLight valued at $787 million after shares jump in Nasdaq debut

October 27, 2025

© 2025 WNyuz.com

No Result
View All Result
  • Home
  • Politics
  • Opinion
  • Business
  • World
  • Health
  • Entertainment
  • Tech

© 2025 WNyuz.com